BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
Health Canada approves Rituxan for treatment of NHL
April 7, 2000
Oncolytics Biotech's pilot canine study of Reolysin shows measurable tumor response
April 4, 2000
Avax begins phase II study of M-Vax in stage IV metastatic melanoma
April 3, 2000
AltaRex presents clinical plan for OvaRex at BIO 2000 annual meeting
March 30, 2000
SRL-172 associated with significantly improved survival in SCLC patients
March 28, 2000
Phase I clinical study to begin with Reolysin as cancer treatment
March 27, 2000
FDA grants orphan drug status to Zadaxin for treatment of liver cancer
March 24, 2000
Phase I study of AltaRex's BrevaRex MAb completed
March 22, 2000
StressGen initiates phase II study with HspE7 in high-grade cervical dysplasia
March 22, 2000
FDA's ODAC recommends approval of Mylotarg for relapsed AML
March 21, 2000
Previous
1
2
…
946
947
948
949
950
951
952
953
954
…
1004
1005
Next
RSS